Occasionally a patient with a neoplastic disease will develop lactic acidosis. Failure to control the lactic acidosis is a poor prognostic sign.
Neoplastic diseases associated with lactic acidosis:
(1) leukemia
(2) malignant non-Hodgkin's lymphoma
(3) Hodgkin's lymphoma
(4) small cell undifferentiated or other lung cancers
(5) other solid tumors
Clinical findings:
(1) tachypnea
(2) tachycardia
(3) abdominal pain
(4) hepatomegaly (with liver metastases)
(5) unexplained clinical deterioration
Laboratory findings:
(1) metabolic acidosis with pH < 7.3
(2) lactic acid > 5 mmol/L
Risk factors:
(1) higher tumor burden (which may be related with increased glycolysis)
(2) extensive liver metastasis and/or severe hepatic dysfunction
(3) impaired renal clearance of lactate
Diagnosis as being paraneoplastic requires exclusion of other causes of lactic acidosis.
The mainstay of therapy is chemotherapy to reduce the tumor burden.
Exogenous buffer may need to be given in severe acidosis to temporarily stabilize the patient while chemotherapy reduces the tumor burden. Bicarbonate has been associated with increased production of lactic acid.
Purpose: To evalaute a patient with a neoplastic disease for tumor-associated lactic acidosis.
Specialty: Endocrinology, Clinical Laboratory, Emergency Medicine, Critical Care
Objective: laboratory tests, severity, prognosis, stage, complications
ICD-10: E87.2, C78.0, E22.2,